Skip to main content

Lipidio Pharmaceuticals

San Diego, United States

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

$20.0M raised
Nov 2022
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lipidio Pharmaceuticals

How much funding has Lipidio Pharmaceuticals raised?
Lipidio Pharmaceuticals has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Who are Lipidio Pharmaceuticals's investors?
Lipidio Pharmaceuticals's investors include 3E Bioventures, Alethea Capital Management, John Maraganore, Nancy Chang, The Foundation for Prader-Willi Research.
Where is Lipidio Pharmaceuticals headquartered?
Lipidio Pharmaceuticals is headquartered in San Diego, United States.
What does Lipidio Pharmaceuticals do?
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
What stage is Lipidio Pharmaceuticals at?
Lipidio Pharmaceuticals is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lipidio Pharmaceuticals — Funding & Investors." VCBacked, November 10, 2022, https://www.vcbacked.co/company/lipidio-pharmaceuticals. Accessed July 3, 2026.
APA
VCBacked. (2022). Lipidio Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/lipidio-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Lipidio Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/lipidio-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .